Cytheris SA: Clinical Trials

9 trials sponsored by Cytheris SA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 3 terminated, 3 unknown. 7 Phase 2, 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Unknown 3, Completed 2, Terminated 2
Phase 16Unknown 3, Completed 2, Terminated 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients
ART Intensification, Immunomodulation - HIV-1 Infection
Phase 2CompletedObjectif Recherche Vaccins SIDA292010-09-012013-06-13
Randomized Study on Multiple Cycles of Interleukin-7 in HIV Patients Immune Non-responders
CYT107 - HIV
Phase 2TerminatedCytheris SA922010-09-012013-07-25
Study on Interleukin-7 (CYT107) in HIV Patients
Interleukin-7 - HIV
Phase 2TerminatedCytheris SA232010-01-012013-08-01
Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients
CYT107+GenHevac+entecavir or tenofovir, CYT107+ entecavir or tenofovir - Chronic Hepatitis B
Phase 1 / Phase 2UnknownCytheris SA242009-12-012012-10-18
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy
Interleukin-7 - Hepatitis C
Phase 1 / Phase 2UnknownCytheris SA152009-01-012012-10-18
Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy Alone
Interleukin-7 - Hepatitis C
Phase 1 / Phase 2UnknownCytheris SA182008-07-012012-10-18
Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)
Interleukin-7 - Hepatitis C
Phase 1 / Phase 2CompletedCytheris SA102007-05-012012-10-18
Safety Study of IL-7 in HIV-infected Patients (Inspire)
CYT 107 - HIV Infections, Lymphopenia
Phase 1CompletedCytheris SA302007-05-012012-10-18
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
recombinant interleukin-7, gene expression analysis, polymerase chain reaction - Kidney Cancer, Melanoma (Skin)
Phase 1TerminatedCytheris SA92007-05-012012-10-18

Conditions studied

Virus Diseases (5)  ·  Hepatitis, Chronic (4)  ·  Liver Diseases (4)  ·  Hepatitis C (3)  ·  Carcinoma, Renal Cell (1)  ·  Communicable Diseases (1)  ·  HIV Infections (1)  ·  Hepatitis B (1)  ·  Hepatitis B, Chronic (1)  ·  Kidney Neoplasms (1)  ·  Lymphopenia (1)  ·  Melanoma (1)

Interventions

Interleukin-7 (6)  ·  Flow Cytometry (1)  ·  Gene Expression Profiling (1)  ·  Immunoenzyme Techniques (1)  ·  Immunologic Techniques (1)  ·  Immunomodulation (1)  ·  Polymerase Chain Reaction (1)  ·  Tenofovir (1)  ·  efineptakin alfa (1)

Countries

Italy (6)  ·  France (5)  ·  Switzerland (3)  ·  United States (3)  ·  Canada (2)  ·  South Africa (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United Kingdom (1)

Top investigators

Tilman Gerlach (2)  ·  Christophe Hezode (1)  ·  Irini Sereti (1)  ·  Michael Lederman (1)  ·  Michael M. Lederman,, Pr (1)  ·  Pietro Andreone (1)  ·  Steven A. Rosenberg, MD, PhD (1)  ·  Wang-Long Chuang, MD (1)  ·  Yves Levy (1)

Results publications

PMID 26908786, PMID 26684819

NIH funding

2009 (1)